Income Statement (TTM)
Hamlet BioPharma AB (publ) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 5 | 6 | 9 | 10 | 13 | 13 | 10 | 6 | 1 | 0 | 2 | 2 | 2 | 2 | -0 | -0 | 0 | 0 |
| Change (%) | 47.67 | 26.92 | 44.39 | 9.99 | 29.34 | -1.71 | -23.50 | -39.42 | -76.98 | -83.92 | 946.89 | 0.36 | 1.28 | -0.36 | -100.36 | 352.14 | -562.73 | 16.83 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| Gross Operating Profit | 3 | 5 | 6 | 9 | 10 | 13 | 13 | 10 | 6 | 1 | 0 | 2 | 2 | 2 | 2 | -0 | -0 | 0 | 0 |
| Change (%) | 47.67 | 26.92 | 44.39 | 9.99 | 29.34 | -1.71 | -23.50 | -39.42 | -76.98 | -83.92 | 946.89 | 0.36 | 1.28 | -0.36 | -100.36 | 352.14 | -562.73 | 16.83 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 26 | 22 | 20 | 17 | 18 | 21 | 23 | 27 | 27 | 25 | 25 | 22 | 24 | 24 | 29 | 34 | 39 | 39 | 45 |
| Change (%) | -13.73 | -11.19 | -15.71 | 6.48 | 17.50 | 8.60 | 18.95 | -1.02 | -4.79 | -0.14 | -11.93 | 6.70 | 2.24 | 17.82 | 16.61 | 14.81 | 0.57 | 15.48 | |
| % of Revenue | 753.23 | 440.06 | 307.93 | 179.77 | 174.03 | 158.11 | 174.70 | 271.64 | 443.82 | 1,835.67 | 11,400.59 | 959.10 | 1,019.63 | 1,029.28 | 1,217.06 | -394,928.21 | -100,277.79 | 21,795.28 | 21,542.99 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 26 | 22 | 20 | 17 | 18 | 21 | 23 | 27 | 27 | 26 | 25 | 23 | 26 | 29 | 36 | 44 | 49 | 49 | 55 |
| Change (%) | -13.55 | -11.17 | -15.69 | 6.27 | 17.50 | 8.45 | 18.93 | -1.04 | -4.79 | -0.13 | -10.23 | 14.06 | 12.07 | 23.90 | 21.82 | 11.38 | 0.47 | 12.04 | |
| % of Revenue | 754.61 | 441.80 | 309.22 | 180.56 | 174.45 | 158.48 | 174.88 | 271.87 | 444.13 | 1,836.93 | 11,409.42 | 978.36 | 1,111.82 | 1,230.30 | 1,529.76 | -518,573.49 | -127,740.14 | 27,735.35 | 26,597.83 |
| Operating Income | -23 | -17 | -13 | -8 | -8 | -8 | -10 | -17 | -21 | -24 | -25 | -21 | -24 | -27 | -34 | -44 | -49 | -49 | -55 |
| Change (%) | -22.90 | -22.31 | -44.40 | 1.65 | 1.60 | 25.84 | 75.60 | 21.29 | 16.19 | 4.69 | -18.69 | 15.61 | 13.14 | 26.04 | 30.37 | 11.44 | 0.03 | 12.02 | |
| % of Revenue | -654.61 | -341.80 | -209.22 | -80.56 | -74.45 | -58.48 | -74.88 | -171.87 | -344.13 | -1,736.93 | -11,309.42 | -878.36 | -1,011.82 | -1,130.30 | -1,429.76 | 518,673.48 | 127,840.13 | -27,635.36 | -26,497.83 |
| Interest Expense | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||||
| Change (%) | -3.53 | -100.00 | -∞ | 36.96 | 0.07 | 0.04 | -74.81 | -99.22 | -44.61 | -33.74 | |||||||||
| % of Revenue | -0.30 | -0.20 | 0.00 | -2.35 | -2.93 | -2.27 | -2.31 | -0.76 | -0.01 | -0.02 | -0.10 | -0.13 | |||||||
| Net Income | -23 | -17 | -13 | -8 | -8 | -8 | -10 | -17 | -21 | -24 | -25 | -20 | -24 | -27 | -33 | -43 | -48 | -49 | -55 |
| Change (%) | -22.89 | -22.36 | -42.75 | 2.65 | 1.54 | 24.87 | 71.11 | 20.76 | 15.71 | 4.71 | -18.76 | 15.70 | 12.43 | 25.63 | 29.47 | 12.10 | 0.43 | 12.23 | |
| % of Revenue | -654.74 | -341.88 | -209.13 | -82.91 | -77.38 | -60.75 | -77.18 | -172.63 | -344.14 | -1,729.91 | -11,265.73 | -874.19 | -1,007.81 | -1,118.81 | -1,410.60 | 508,198.33 | 125,996.10 | -27,346.83 | -26,270.61 |
Source: Capital IQ
